Table 2.
Results of antibiotic susceptibility tests of Acinetobacter sp. DW-1.
| Antimicrobial agents | Breakpoints (mm) | Tolerance (Breakpoints (mm)) | ||
|---|---|---|---|---|
| Susceptible (S) | Intermediate (I) | Resistant (R) | ||
| Kanamycin(K) | ≥18 | 14–17 | ≤13 | S(26.96) |
| Streptomycin(S) | ≥15 | 11–14 | ≤10 | S(16.09) |
| Tetracycline(TE) | ≥19 | 15–18 | ≤14 | S(20.02) |
| Ampicillin(AMP) | ≥17 | 14–16 | ≤13 | S(14.72) |
| Chloramphenicol(C) | ≥26 | 20–25 | ≤19 | R(15.84) |
| Ciprofloxacin(CIP) | ≥21 | 16–20 | ≤15 | S(25.69) |
| Meropenem(MEM) | ≥16 | 14–15 | ≤13 | S(29.55) |
| Cephalothin(KF) | ≥18 | 15–17 | ≤14 | S(21.52) |
| Tobramycin(TOB) | ≥15 | 13–14 | ≤12 | S(21.61) |
| Gentamicin(CN) | ≥15 | 13–14 | ≤12 | S(20.21) |
| Ceftazidime(CAZ) | ≥21 | 18–20 | ≤17 | I(18.86) |
| Cefotaxime(CTX) | ≥23 | 15–22 | ≤14 | I(17.67) |
| Imipenem(IPM) | ≥16 | 14–15 | ≤13 | S(28.67) |
| Cefepime(FEP) | ≥18 | 15–17 | ≤14 | S(19.45) |
| Trimethoprim-Sulfamethoxazoie(SXT) | ≥16 | 11–15 | ≤10 | S(19.07) |
| Levofloxacin(LEV) | ≥17 | 14–16 | ≤13 | S(29.38) |
| Aztreonam (ATM) | ≥21 | 18–20 | ≤17 | R(0) |